Developmental changes in serotonin 2C receptor mRNA editing in the rat cerebral cortex and primary cultured cortical neurons

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 2, 2009, Pages 289-292

  Tohda, Michihisa ^a   Hang, Pham Nguyet Thi ^a   Matsumoto, Kinzo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Depression; Neuronal development; Primary cultured cortical cell; RNA editing; Serotonin 2c receptor

Indexed keywords

MESSENGER RNA; RECEPTOR PROTEIN; SEROTONIN 2C RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN DEVELOPMENT; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTNATAL DEVELOPMENT; RAT; RNA EDITING;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; FEMALE; NEURONS; PREGNANCY; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA EDITING; RNA, MESSENGER;

EID: 60749109008     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.289     Document Type: Article

References (21)

1. Barnes N. M., Sharp T., Neuropharmacology, 38, 1083-1152 (1999).
2. Li Q. H., Nakadate K., Tanaka-Nakadate S., Nakatsuka D., Cui Y., Watanabe Y., J Comp. Neurol., 469, 128-140 (2004).
3. Pandey G. N., Dwivedi Y., Ren X., Rizavi H. S., Faludi G., Sarosi A., Palkovits M., Neurochem. Res., 31, 167-176 (2006).
4. Seeburg P. H., Higuchi M., Sprengel R., Brain Res. Brain Res. Rev., 26, 217-229 (1998).
5. Ohlson J., Pedersen J. S., Haussler D., Ohman M., RNA, 13, 698-703 (2007).
6. Burns C. M., Chu H., Rueter S. M., Hutchinson L. K., Canton H., Sanders-Bush E., Emeson R. B., Nature (London), 387, 303-308 (1997).
7. Gurevich I., Tamir H., Arango V., Dwork A. J., Mann J. J., Schmauss C., Neuron, 34, 349-356 (2002).
8. Iwamoto K., Kato T., Neurosci. Lett., 346, 169-172 (2003).
9. Niswender C. M., Herrick-Davis K., Dilley G. E., Meltzer H. Y., Over-holser J. C., Stockmeier C. A., Ronald B., Emeson R. B., Sanders-Bush E., Neuropsychopharmacology, 24, 478-491 (2001).
10. Tohda M., Nomura M., Nomura Y., J Pharmacol. Sci., 100, 427-432 (2006).
11. Sodhi M. S., Burnet P. W., Makoff A. J., Kerwin R. W., Harrison P. J., Mol. Psychiatry, 6, 373-379 (2001).
12. Sodhi M. S., Sanders-Bush E., Int. Rev. Neurobiol., 59, 111-174 (2004).
13. Sukma M., Tohda M., Watanabe H., J. Pharmacol. Sci., 92, 433-436 (2003).
14. Hang P. N. T., Tohda M., Matsumoto K., Neurosci. Res., 61, 398-403 (2008).
15. Brewer G. J., J. Neurosci. Res., 42, 674-683 (1995).
16. Julius D., Livelli T. J., Jessell T. M., Axel R., Science, 244, 1057-1062 (1989).
17. Berg K. A., Dunlop J., Sanchez T., Silva M., Clarke W. P., J. Pharmacol. Exp. Ther., 324, 1084-1092 (2008).
18. Wang Q., Khillan J., Gadue P., Nishikura K., Science, 290, 1765-1768 (2000).
19. Higuchi M., Maas S., Single F. N., Hartner J., Rozov A., Burnasjev N., Feldmeyer D., Sprengel R., Seeburg P. H., Nature (London), 406, 78-81 (2000).
20. Iwamoto K., Nakatani N., Bundo M., Yoshikawa T., Kato T., Neurosci. Res., 53, 69-76 (2005).
21. Gurevich I., Englander M. T., Adlersberg M., Siegal N. B., Schmauss C., J. Neurosci., 22, 10529-10532 (2002).